get a key
steadybase-$ company CAMP
account_id none on file
legal_name Camp4 Therapeutics Corp
ticker CAMP
cik 1736730
domain camp4tx.com
entry_point_account_id none on file
name CAMP4 Therapeutics Corporation
exchange Nasdaq
calls 2 filings 0 executives 2 family 0
why_nownone on file
calls
I want to reiterate once again that we continue to monitor all COVID-19 developments across our worldwide operations and that the cost controls we put in place, particularly in areas such as personnel, travel, and other discretionary spending remain in place.

Sep 24, 2020 / receipt, needs a key / Kurt Bender, CFO | earnings call 2020-09-24 | transcript cd2afc58-f033-462a-9af1-4e5eed083415 | chars 7883-8142 | segment 8

We continue to manage our spend carefully in this period of uncertainty, and our focus has been on closely managing personnel costs, including delayed hiring as well as the timing of discretionary spend around T&E, professional services, and marketing, among others.

Sep 24, 2020 / receipt, needs a key / Kurt, CFO | earnings call 2020-09-24 | transcript cd2afc58-f033-462a-9af1-4e5eed083415 | chars 13621-13887 | segment 13

filingsnone on file
executives
familynone on file
upcoming
2026-11-05 earnings call scheduled ir
changesnone on file
mcp_package_hint
steadybase-$